» Articles » PMID: 21060747

Cardiovascular Diseases After Kidney Transplantation in Korea

Overview
Specialty General Medicine
Date 2010 Nov 10
PMID 21060747
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular disease (CVD) is the leading cause of death in renal allograft recipients with functioning graft. Our study aimed to determine the incidence and the risk factors of cardiovascular disease after renal transplantation in Korea. We retrospectively analyzed 430 adult recipients who underwent kidney transplantation between January 1997 and February 2007. CVD was defined as a composite outcome of ischemic heart disease, cerebrovascular accident and peripheral vascular disease. Mean age of recipients was 40.0±11.8 yr. Mean duration of follow-up was 72±39 months. The cumulative incidence of CVD after renal transplantation was 2.4% at 5 yr, 5.4% at 10 yr and 11.4% at 12 yr. Multivariate analysis revealed that recipient's age, diabetes mellitus and duration of dialysis before transplantation were associated with post-transplant CVD (hazard ratio 1.843 [95% CI, 1.005-3.381], 3.846 [95% CI, 1.025-14.432] and 3.394 [95% CI, 1.728-6.665] respectively). In conclusion, old age, duration of dialysis and diabetes mellitus are important risk factors for post-transplant CVD, although the incidence of post-renal transplant CVD is lower in Korea than that in western countries.

Citing Articles

The Korean Organ Transplantation Registry (KOTRY): an overview and summary of the kidney-transplant cohort.

Jeon H, Koo T, Ju M, Chae D, Choi S, Kim M Kidney Res Clin Pract. 2022; 41(4):492-507.

PMID: 35919926 PMC: 9346403. DOI: 10.23876/j.krcp.21.185.


Rituximab protects against development of atherosclerotic cardiovascular disease after kidney transplantation: a propensity-matched study.

Kim D, Lee J, Seo W, Lee J, Kim B, Kim M Sci Rep. 2019; 9(1):16475.

PMID: 31712593 PMC: 6848081. DOI: 10.1038/s41598-019-52942-8.


The prognostic significance of preoperative left ventricular diastolic dysfunction and left atrial enlargement on acute coronary syndrome in kidney transplantation.

Hwang J, Park J, Kim Y, An J, Yang J, Ahn C Oncotarget. 2017; 8(41):71154-71163.

PMID: 29050351 PMC: 5642626. DOI: 10.18632/oncotarget.16862.


Design and Methods of the Korean Organ Transplantation Registry.

Yang J, Jeong J, Lee J, Kim Y, Paik H, Kim J Transplant Direct. 2017; 3(8):e191.

PMID: 28856244 PMC: 5540629. DOI: 10.1097/TXD.0000000000000678.


Early onset hyperuricemia is a prognostic marker for kidney graft failure: Propensity score matching analysis in a Korean multicenter cohort.

Han M, Lee J, Park S, Kim Y, Kim Y, Ahn C PLoS One. 2017; 12(5):e0176786.

PMID: 28467476 PMC: 5415138. DOI: 10.1371/journal.pone.0176786.


References
1.
Kasiske B, Chakkera H, Roel J . Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol. 2000; 11(9):1735-1743. DOI: 10.1681/ASN.V1191735. View

2.
Harland J, Unwin N, Bhopal R, White M, Watson B, Laker M . Low levels of cardiovascular risk factors and coronary heart disease in a UK Chinese population. J Epidemiol Community Health. 1998; 51(6):636-42. PMC: 1060560. DOI: 10.1136/jech.51.6.636. View

3.
Morales J, Dominguez-Gil B . Impact of tacrolimus and mycophenolate mofetil combination on cardiovascular risk profile after kidney transplantation. J Am Soc Nephrol. 2006; 17(12 Suppl 3):S296-303. DOI: 10.1681/ASN.2006080930. View

4.
Kasiske B, Maclean J, Snyder J . Acute myocardial infarction and kidney transplantation. J Am Soc Nephrol. 2006; 17(3):900-7. DOI: 10.1681/ASN.2005090984. View

5.
Kim H, Kang S, Lee H, Choi D, Shim W, Kim S . Correlates of the severity of coronary atherosclerosis in long-term kidney transplant patients. J Korean Med Sci. 2010; 25(5):706-11. PMC: 2858828. DOI: 10.3346/jkms.2010.25.5.706. View